Abingdon Health plc
("Abingdon Health",
the "Group" or the "Company")
Notice of Annual General
Meeting
York, U.K. 21
October 2024: Abingdon Health plc (AIM: ABDX),
a leading international lateral flow contract research (CRO) and
contract development and manufacturing organisation (CDMO),
announces that its Annual General Meeting ('AGM') will be held on
Tuesday 19 November 2024 at 10:00 GMT at the Company's offices at
York Biotech Campus, Sand Hutton, York, YO41 1LZ, United
Kingdom.
Printed copies of the Notice of the AGM and
2024 Annual Report have been posted to registered shareholders who
have elected to receive paper communications and will shortly be
available on the Company's website:
https://www.abingdonhealth.com/investors/documents-and-reports/
Enquiries:
|
Abingdon Health plc
|
www.abingdonhealth.com/investors/
|
|
Chris
Yates, Chief Executive
Officer
|
Via
Walbrook PR
|
|
Chris
Hand, Executive Chairman
|
|
|
Zeus Capital (Sole Broker and
Nominated Adviser)
|
Tel: +44 (0)20 3829 5000
|
|
Chris Fielding / Isaac
Hooper / Alexandra Campbell-Harris (Corporate
Finance)
|
|
|
Fraser Marshall (Corporate
Broking)
|
|
|
Walbrook PR (Media & Investor
Relations)
|
Tel: +44 (0)20 7933
8780 or abingdon@walbrookpr.com
|
|
Paul McManus / Alice
Woodings
|
Mob: +44 (0)7980 541
893 / +44 (0)7407 804 654
|
|
Phillip Marriage
|
+44 (0)7867 984
082
|
|
|
|
| |
About Abingdon Health plc
Abingdon Health Group is a
leading med-tech contract service provider offering its services to
an international customer base.
The
Company's CDMO
division offers lateral flow
product development, regulatory support, technology transfer and
manufacturing services for customers looking to develop new assays
or transfer existing laboratory-based assays to a lateral flow
format. Abingdon Health's CDMO division has the internal
capabilities to take lateral flow projects, in areas such as
infectious disease and clinical testing, including companion
diagnostics, animal health and environmental testing, from initial
concept through to routine and large-scale manufacturing; from
"idea to commercial success".
Abingdon's regulatory services
companies, Compliance
Solutions (Life Sciences) and IVDeology,
provide a broad range of regulatory services to the in vitro
diagnostic and wider medical device industry, to support customers
in bringing products to market across a range of territories
including the USA, EU and the UK. Our consultancy
services range from design, implementation and maintenance of
quality management systems, preparation of technical files for
regulatory approvals, part-time and interim management support,
auditing both internal and external, management reviews and
presentations, training and mentoring.
Abingdon Health's Abingdon
Simply Test range of self-tests is an e-commerce platform that
offers a range of self-tests to empowers consumers to manage their
own health and wellbeing. The Abingdon
Simply Test e-commerce site offers
consumers a range of information to support them in making informed
decisions on the tests available. In addition, the site provides
Abingdon's contract services customers with a potential route to
market for self-tests. The Abingdon Simply Test range is also sold
through international distributors and through other channels in
the UK and Ireland, such as pharmacy
chains.
Founded in 2008, Abingdon
Health is headquartered in York, England.
For more information
visit: www.abingdonhealth.com